Fig. 2From: Serum neurofilament measurement improves clinical risk scores for outcome prediction after cardiac arrest: results of a prospective studySubgroup analysis of NfL for primary endpoint (neurological outcome). Data is presented as univariable odds ratio (OR) and 95% confidence interval (95% CI). NfL: Neurofilament Light Chain; TTM: Targeted Temperature Management, COPD: Chronic obstructive pulmonary diseaseBack to article page